DIAMOND
A Multicenter, Double-blind, Placebo-controlled, Randomized Withdrawal, Parallel Group Study of Patiromer for the Management of Hyperkalemia in Subjects Receiving Renin-Angiotensin-Aldosterone System Inhibitor (RAASi) Medications for the Treatment of HF.
- Stadium
- klaar
- Middel
- Patiromer
- Populatie
- Hartfalen
- Fase
- IIIb
- First Patient In
- 9 oktober 2020
- Last Patient In
- 24 juni 2021
- Last Patient Last Visit
- -
National Lead
dr. Brugts
Cardioloog
Studiedirecteur
